Sydney - Tuesday - April 24: (RWE Australian Business News) - ResMed Inc (ASX: RMD) reports revenue for the quarter ended March 31 was US$183.0 million, a 13% increase. Income from operations and net income were US$44.3 million and US$31.1 million, an increase of 5% and 3%. Diluted earnings per share for the quarter were US$0.39. GAAP operating loss was US$21.9 million for the current quarter, while GAAP net loss was US$15.4 million or US$0.20 per diluted share. These results were significantly impacted by a US$59.7 million (US$41.8 million net of tax) charge for voluntary product recall expenses. Gross margin was 29.6%
RMD Price at posting:
0.0¢ Sentiment: Buy Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)